VitaNova Life Sciences (VNOV) Return on Capital Employed (2019 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Return on Capital Employed came in at 0.18% in Q2 2026, down 8366.0% YoY from 0.0% in Q2 2025, and down 99.72% on a QoQ basis from 64.08% in Q1 2026.
VitaNova Life Sciences (VNOV) Return on Capital Employed (2019 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 6 years of Return on Capital Employed data on file, last reported at 0.18% in Q2 2026.
- Quarterly Return on Capital Employed fell 8366.0% year-over-year to 0.18% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.18% (down 8366.0% YoY) and the FY2026 annual result came in at 0.18%, down 8757.0% from the prior year.
- Return on Capital Employed fell to 0.18% in Q2 2026, from 64.08% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 310.01% in Q1 2022 to a low of 12.04% in Q4 2022.
- A 5-year average of 69.82% and a median of 64.08% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 22143 bps — and 2025, when it jumped 6201 bps.
- Tracing VNOV's Return on Capital Employed over 5 years: stood at 12.04% in 2022, then surged by 321 bps to 26.59% in 2023, then retreated by 4 bps to 25.43% in 2024, then jumped by 167 bps to 67.95% in 2025, then tumbled by 100 bps to 0.18% in 2026.
- The last three Return on Capital Employed figures came in at 0.18% (Q2 2026), 64.08% (Q1 2026), and 67.95% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 43.39% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 12.93% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 19.96% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 8.66% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -74.44% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 1.84% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -6.99% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -67.72% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 0.18% |
| Jan 31, 2026 | 64.08% |
| Oct 31, 2025 | 67.95% |
| Jul 31, 2025 | 65.33% |
| Apr 30, 2025 | 83.84% |
| Jan 31, 2025 | 33.30% |
| Oct 31, 2024 | 25.43% |
| Jul 31, 2024 | 18.49% |
| Apr 30, 2024 | 21.84% |
| Apr 30, 2023 | 26.59% |
| Jan 31, 2023 | 88.58% |
| Oct 31, 2022 | -12.04% |
| Jul 31, 2022 | 83.99% |
| Apr 30, 2022 | 169.64% |
| Jan 31, 2022 | 310.01% |
| Jan 31, 2019 | 123.43% |